Comparing Magnetic Resonance Imaging/Spectroscopy Techniques

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

49946 participants

Study Classification

OBSERVATIONAL

Study Start Date

1987-06-18

Study Completion Date

2020-06-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) are diagnostic tests that allow researchers to look at different chemical properties of tissue. Magnetic resonance imaging and spectroscopy studies can be used to gather or evaluate information about various aspects of patient s bodies or to monitor changes in the biochemistry and physiology of patient s bodies.

Unlike other diagnostic techniques (CT scan and PET scan) MRI and MRS do not use ionizing radiation. Some studies have shown that MRI is more effective at distinguishing normal parts of the anatomy from abnormal anatomy, especially in the brain. MRI has become the diagnostic test of choice for evaluating patient with multiple sclerosis.

The purpose of this study is to evaluate normal volunteers and patients with a variety of diseases with magnetic resonance imaging. Researchers will attempt different magnetic resonance imaging methods and techniques as well as different levels of magnetic strength.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Refinement and Assessment of New MRI Technologies for Thoracic/ Cardiovascular Exams

NCT00727792

Magnetic Resonance Imaging (MRI) of the Chest

COMPLETED NA

Toward an Automated Method of Abdominal Fat Segmentation of MR Images

NCT01228968

Obesity

COMPLETED

Technical Evaluation of Cardiovascular Magnetic Resonance Imaging and Spectroscopy

NCT00001874

Cardiovascular Disease Healthy

COMPLETED

Development of 3T Magnetic Resonance Research Methods for NIA Studies

NCT01324206

Normal Physiology

RECRUITING

Diagnostic Accuracy of MR in Myositis

NCT01702870

Myositis Muscular Disorders, Atrophic

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background:

MRI is a constantly evolving imaging modality. Pulse sequences are often modified to improve their performance. However, many of these changes have not yet been approved by the FDA and therefore, are not considered standard of care. Some of these sequences require the use of new types of imaging coils, which are also investigational.

Objectives:

The major purpose of this protocol is to inform patients undergoing MR scans in the Clinical Center that they be scanned with MRI sequences and/or coils which may or may not be FDA approved and to get the patient s consent for this. This is not a formal research study since specific disease entities and specific pulse sequences are not studied in a systematic way. Rather, the purpose is to give NIH patients access to gradual improvements in MR technology that would otherwise not be available to them.

Eligibility:

All patients who, by virtue of the NIH protocol in which they are enrolled, qualify for MRI will be eligible for participation in this protocol.

Design:

Up to 99,999 participants will be enrolled in this study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Abdominal Organs - Lipodystrophy Tumors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients undergoing MRI in the Clinical Center

All patients who, by virtue of the NIH protocol in which they are enrolled, who qualify for MRI will be eligible for participation in this protocol.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients undergoing MRI in the Clinical Center.
* Patients must be able to provide informed consents.

Exclusion Criteria

* Contraindications to MRI.
* Inability to understand consent form or consent process and the absence of a suitable guardian.
* Adults who are or may not be able to consent
* Patients in whom the scan must be performed quickly, i.e. those patients under anesthesia, anxious patients, those requiring emergency medical care, or others in which it is deemed inappropriate to prolong a study.
* Refusal to Participate.
* Pregnant women and fetuses
* Neonates

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No